Loading...
Loading...
Riverbed Technology
RVBD dipped 17.46% to $14.47 in the pre-market session after the company reported downbeat second-quarter revenue.
Optimer Pharmaceuticals
OPTR shares fell 6.47% to $12.43 in the pre-market trading after Cubist Pharmaceuticals
CBST announced its plans to acquire Trius Therapeutics
TSRX and Optimer for up to $1.62 billion.
BioCryst Pharmaceuticals
BCRX shares dropped 5.78% to $3.75 in pre-market trading after the company announced its plans to sell up to $20 million in common stock.
Genworth Financial
GNW dipped 3.82% to $12.85 in the pre-market session after the company reported weaker-than-expected second-quarter results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in